Patent · US Expired

Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

US7303749B1 · kind B1 · utility

139Cited by
6References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 29, 2000
Grant dateDec 4, 2007
Priority date
Expiry dateSep 29, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is based on the discovery that the administration of at least one immunoconjugate and at least one chemotherapeutic agent provides an unexpectedly superior treatment for cancer. The present invention is directed to compositions comprising at least one immunoconjugate and at least one chemotherapeutic agent and to methods of treating cancer using at least one immunoconjugate and at least one chemotherapeutic agent. The present invention also provides methods of modulating the growth of selected cell populations, such as cancer cells, by administering a therapeutically effective amount of at least one chemotherapeutic agent and at least one immunoconjugate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.